TTD | Drug: D02JYA

Drug General Information
Drug ID	D02JYA
Former ID	DNAP001277
Drug Name	Raxibacumab
Drug Type	Monoclonal antibody
Indication	Anthrax [ICD9: 22; ICD10:A00-B99]		Approved	[531382]
Company	GlaxoSmithKline
CAS Number	CAS 565451-13-0
Target and Pathway
Target(s)	Protective antigen	Target Info	Modulator	[531382]
Pathway Interaction Database	Cellular roles of Anthrax toxin
Reactome	Uptake and function of anthrax toxins
References
Ref 531382	Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43.
Ref 531382	Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information